Cas:5626-36-8 N-Nonyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine manufacturer & supplier

We serve Chemical Name:N-Nonyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine CAS:5626-36-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-Nonyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

Chemical Name:N-Nonyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS.NO:5626-36-8
Synonyms:Acetic acid,2-bromo-,nonyl ester;Nonyl bromoacetate
Molecular Formula:C15H24N4
Molecular Weight:260.37800
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:440.5ºC at 760mmHg
Density:1.085g/cm3
Index of Refraction:1.594
PSA:53.60000
Exact Mass:260.20000
LogP:4.19340

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Acetic acid,2-bromo-,nonyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Nonyl bromoacetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Acetic acid,2-bromo-,nonyl ester Use and application,Acetic acid,2-bromo-,nonyl ester technical grade,usp/ep/jp grade.


Related News: British Airways, Qantas and Lufthansa — among others — have announced they will stop flying to mainland China. Other airlines are reducing the number of flights. N-Nonyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine manufacturer The continuous acceleration of the industrial transfer process has provided a huge market space for the fine chemical intermediate industry. N-Nonyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine supplier As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company��s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations. N-Nonyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine vendor Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells. N-Nonyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine factory British Airways, Qantas and Lufthansa — among others — have announced they will stop flying to mainland China. Other airlines are reducing the number of flights.